nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acanthamoeba keratitis: an increasingly common infectious disease of the cornea
|
Rayamajhee, Binod |
|
|
2 |
8 |
p. e345-e346 |
artikel |
2 |
A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study
|
Yokota, Isao |
|
|
2 |
8 |
p. e397-e404 |
artikel |
3 |
Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
|
Otu, Akaninyene |
|
|
2 |
8 |
p. e347-e348 |
artikel |
4 |
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
|
Russell, Clark D |
|
|
2 |
8 |
p. e354-e365 |
artikel |
5 |
Convalescent plasma transfusion for pregnant patients with COVID-19
|
Mastroianni, Antonio |
|
|
2 |
8 |
p. e350 |
artikel |
6 |
Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys
|
Whittaker, Charles |
|
|
2 |
8 |
p. e366-e374 |
artikel |
7 |
Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis
|
Du Bruyn, Elsa |
|
|
2 |
8 |
p. e375-e385 |
artikel |
8 |
Invasive mould disease in fatal COVID-19: a systematic review of autopsies
|
Kula, Brittany E |
|
|
2 |
8 |
p. e405-e414 |
artikel |
9 |
Mucormycosis: time to address this deadly fungal infection
|
Stone, Neil |
|
|
2 |
8 |
p. e343-e344 |
artikel |
10 |
Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study
|
Badell, Edgar |
|
|
2 |
8 |
p. e386-e396 |
artikel |
11 |
Preventing zoonotic pandemics: are we there yet?
|
Gruber, Karl |
|
|
2 |
8 |
p. e352 |
artikel |
12 |
SARS-CoV-2 emerging variants in Africa: view from Gabon
|
Zoa-Assoumou, Samira |
|
|
2 |
8 |
p. e349 |
artikel |
13 |
SARS-CoV-2 rapid diagnostic tests for emerging variants
|
Bekliz, Meriem |
|
|
2 |
8 |
p. e351 |
artikel |
14 |
UK Government's COVID-19 gamble
|
The Lancet Microbe, |
|
|
2 |
8 |
p. e342 |
artikel |
15 |
2021 WHO guidelines on genetically modified mosquitoes
|
Makoni, Munyaradzi |
|
|
2 |
8 |
p. e353 |
artikel |